Elizabeth A. Garofalo, M.D., has served as an ACADIA director since September 2020. Since 2016 she has been Principal of EAG Pharma Consulting, and she previously held senior leadership roles at Novartis, including Senior Vice President and Global Head of Clinical Development, and served as head of the neuroscience therapy area at Astellas Pharma. She currently serves on the boards of Alector and Xenon Pharmaceuticals. She earned her M.D. from the Indiana University School of Medicine and completed fellowships in pediatric neurology and epilepsy at the University of Michigan.